studi
conduct
analyz
alter
human
serum
proteom
consequ
infect
malaria
parasit
plasmodium
falciparum
p
vivax
obtain
mechanist
insight
diseas
pathogenesi
host
immun
respons
identif
potenti
protein
marker
serum
sampl
patient
diagnos
falciparum
malaria
fm
n
vivax
malaria
vm
n
healthi
control
hc
n
investig
use
multipl
proteom
techniqu
result
valid
employ
immunoassaybas
approach
specif
identifi
malaria
relat
serum
marker
evalu
mean
analysi
leptospirosi
febril
control
fc
compar
hc
differenti
express
statist
signific
serum
protein
identifi
fm
vm
respect
almost
half
protein
commonli
modul
due
plasmodi
infect
protein
found
differenti
express
fm
compar
vm
function
pathway
analysi
involv
identifi
protein
reveal
modul
differ
vital
physiolog
pathway
includ
acut
phase
respons
signal
chemokin
cytokin
signal
complement
cascad
blood
coagul
malaria
panel
identifi
protein
consist
six
candid
serum
amyloid
hemopexin
apolipoprotein
e
haptoglobin
retinolbind
protein
apolipoprotein
ai
use
build
statist
sampl
class
predict
model
employ
plsda
classif
method
clinic
phenotyp
class
fm
vm
fc
hc
predict
predict
accuraci
individu
perform
three
classifi
protein
haptoglobin
apolipoprotein
ai
retinolbind
protein
diagnosi
malaria
analyz
use
receiv
oper
characterist
roc
curv
discrimin
fm
vm
fc
hc
group
basi
differenti
express
serum
protein
demonstr
potenti
analyt
approach
detect
malaria
well
human
diseas
burden
malaria
continu
worsen
global
devast
impact
human
health
correspond
impedi
econom
improv
despit
worldwid
initi
emerg
drug
resist
differ
speci
plasmodium
pauciti
inform
exact
underli
mechan
diseas
pathogenesi
creat
challeng
manag
erad
diseas
plasmodium
falciparum
pf
infect
repres
major
caus
malaria
associ
morbid
mortal
worldwid
falciparum
malaria
fm
account
approxim
million
case
one
million
death
annual
particularli
subsaharan
africa
outsid
african
contin
plasmodium
vivax
pv
respons
malaria
case
order
surviv
within
host
cell
ensur
reproduct
intracellular
parasit
like
plasmodium
develop
versatil
mechan
exploit
host
cell
induc
new
permeabl
pathway
permit
uptak
nutrient
remov
wast
product
result
activ
multipl
host
immun
cascad
inflammatori
respons
plasmodium
infect
also
affect
blood
coagul
divers
pathobiolog
mechan
result
develop
fatal
hemorrhag
complic
investig
parasit
induc
alter
host
proteom
modul
differ
vital
physiolog
process
great
clinic
relev
light
diagnosi
prognosi
recent
proteom
studi
contribut
substanti
understand
clinic
proteom
human
malaria
parasit
profil
humor
immun
respons
plasmodium
infect
malaria
parasit
infectioninduc
chang
host
erythrocyt
membran
protein
find
obtain
studi
provid
better
understand
diseas
pathogenesi
hostpathogen
interact
host
immun
respons
analysi
human
serum
proteom
found
use
identif
potenti
diseaserel
marker
understand
diseas
pathogenesi
host
immun
respons
sinc
variou
serum
protein
exhibit
rapid
alter
express
pattern
respons
diseas
condit
show
direct
correl
diseas
progress
recent
year
number
proteom
studi
carri
investig
pathogen
induc
alter
human
serumplasma
proteom
differ
infecti
diseas
includ
dengu
sar
leishmaniasi
leptospirosi
studi
investig
alter
human
serum
proteom
due
p
falciparum
infect
obtain
mechanist
insight
diseas
pathogenesi
host
immun
respons
virul
form
human
malaria
addit
serum
proteom
chang
fm
compar
vivax
malaria
vm
anoth
wide
distribut
human
malaria
studi
similar
differ
host
respons
two
major
plasmodi
infect
achiev
compar
analysi
util
select
dataset
previou
serum
proteom
studi
vm
addit
proteom
immuneassaybas
experi
perform
use
bigger
compar
previou
report
clinic
cohort
vm
patient
compar
studi
fm
vm
reveal
quit
serum
protein
associ
divers
essenti
physiolog
pathway
includ
acut
phase
respons
signal
cytokin
chemokin
signal
complement
cascad
blood
coagul
commonli
alter
plasmodi
infect
uniqu
modul
candid
calcium
bind
protein
calpain
regul
gprotein
signal
serum
paraoxonasearylesteras
transthyretin
fm
ceruloplasmin
vitamin
dbind
protein
serum
amyloid
p
fibrinogen
beta
chain
precursor
vm
also
identifi
recent
perform
serum
proteom
alter
anoth
clinic
relev
infecti
diseas
leptospirosi
evalu
specif
identifi
protein
target
elimin
gener
febril
respons
express
level
serum
protein
differenti
express
plasmodi
infect
compar
healthi
subject
analyz
leptospirosi
patient
previou
studi
anoth
major
intent
present
studi
identif
characterist
marker
protein
readili
discrimin
malaria
patient
fm
vm
well
healthi
popul
well
close
relat
infecti
diseas
high
accuraci
potenti
serum
protein
biomark
identifi
studi
use
build
statist
model
success
classifi
predict
clinic
phenotyp
control
healthi
febril
fm
vm
blind
studi
stringent
inclus
criteria
employ
select
malaria
patient
control
hc
fc
reduc
preanalyt
variat
malaria
patient
fm
vm
select
proteom
analysi
suffer
uncompl
nonsever
plasmodi
infect
compar
rang
parasitemia
blood
sampl
collect
malaria
patient
administr
antimalari
drug
major
patient
suffer
first
episod
malaria
subject
past
histori
diseas
relaps
recurr
averag
age
fm
vm
patient
includ
proteom
analysi
year
sd
rang
median
year
sd
rang
median
respect
tabl
maintain
uniform
popul
profil
test
fm
vm
control
hc
fc
differenti
protein
express
analysi
healthi
febril
control
leptospirosi
patient
popul
compar
age
distribut
mean
valu
year
sd
rang
median
year
sd
rang
median
respect
hc
fc
select
tabl
proteom
studi
perform
two
level
gelbas
proteom
analysi
use
classic
twodimension
gel
classic
analysi
patient
suffer
first
episod
malaria
well
patient
past
histori
malaria
relaps
recurr
higher
level
parasitemia
infect
rbcsml
blood
includ
sinc
difficult
get
bigger
cohort
malaria
patient
similar
paramet
gelbas
proteom
analysi
sampl
studi
individu
n
classic
n
rather
sampl
pool
achiev
better
insight
biolog
variabl
individu
sampl
proteom
analysi
two
major
highabund
serum
protein
albumin
igg
remov
use
albumin
igg
deplet
spintrap
ge
healthcar
reduc
dynam
rang
serum
proteom
deplet
top
two
highabund
protein
remov
total
protein
content
human
plasma
serum
allow
detect
protein
increas
effect
concentr
lowabund
protein
deplet
albumin
igg
effect
increas
overal
spot
number
gel
figur
effici
albumin
igg
deplet
human
serum
evalu
densitometr
analysi
sdspage
gel
contain
resolv
serum
protein
deplet
figur
densitometr
analysi
reveal
around
deplet
albumin
igg
respect
figur
serum
proteom
analysi
fm
patient
healthi
control
identifi
statist
signific
differenti
express
chang
protein
spot
tabl
stain
gelcod
blue
safe
protein
stain
protein
spot
detect
reproduc
gel
softwar
repres
imag
serum
proteom
profil
fm
subject
healthi
individu
bardiagrammat
represent
fold
chang
view
select
spot
illustr
figur
b
ms
analysi
differ
protein
identifi
differenti
express
protein
spot
sinc
case
ms
analysi
reveal
similar
ident
multipl
protein
spot
appear
differ
entiti
gel
similar
ident
multipl
spot
indic
possibl
presenc
variou
isoform
particular
protein
probabl
due
complex
combin
posttransl
modif
among
identifi
protein
protein
upregul
serum
amyloid
hemopexin
precursor
apolipoprotein
e
precursor
leucinerich
glycoprotein
precursor
protein
downregul
haptoglobin
ficolin
precursor
apolipoprotein
ai
clusterin
precursor
serum
albumin
figur
tabl
interestingli
serum
amyloid
spot
found
highli
express
fm
patient
around
protein
spot
detect
gel
decyd
softwar
analysi
analysi
fm
hc
total
around
entir
detect
spot
differenti
express
spot
satisfi
statist
paramet
ttest
among
protein
spot
upregul
chang
remain
downregul
rang
tabl
spot
spot
found
statist
signific
perform
fals
discoveri
rate
fdr
correct
benjaminihochberg
bonferroni
correct
respect
tabl
differenti
express
spot
fm
compar
hc
identifi
analysi
excis
subject
malditoftof
ms
analysi
obtain
reliabl
ms
id
protein
spot
tabl
remain
spot
remain
unidentifi
produc
virtual
empti
spectra
like
owe
presenc
extrem
diminut
quantiti
protein
indic
retrospect
scrutini
spot
volum
protein
spot
identifi
ms
repres
upregul
downregul
differenti
express
protein
fm
patient
tabl
figur
protein
identifi
experi
also
obtain
addit
new
candid
also
identifi
due
higher
sensit
reproduc
view
graphic
represent
select
protein
spot
shown
figur
comprehens
compar
analysi
host
respons
fm
vm
find
previou
studi
vm
carri
categor
common
uniqu
proteom
alter
human
serum
pf
pv
infect
almost
half
total
identifi
protein
commonli
modul
plasmodi
infect
howev
magnitud
proteom
alter
differ
two
type
malaria
figur
compar
healthi
control
quit
serum
protein
calcium
bind
protein
calpain
regul
gprotein
signal
serum
paraoxonasearylesteras
transthyretin
precursor
found
differenti
express
fm
vm
contrari
protein
like
ceruloplasmin
vitamin
dbind
protein
serum
amyloid
p
fibrinogen
beta
chain
precursor
exhibit
alter
express
vm
patient
tabl
among
protein
differenti
express
compar
hc
malaria
serotransferrin
precursor
transferrin
exhibit
opposit
trend
pf
pv
infect
rest
protein
exhibit
similar
trend
differenti
express
fm
vm
although
foldchang
valu
differ
figur
compar
vm
protein
spot
found
differenti
express
fm
ttest
fdr
benjaminihochberg
bonferroni
correct
protein
spot
remain
signific
respect
tabl
ms
id
protein
spot
obtain
malditoftof
ms
analysi
indic
differenti
express
protein
fm
compar
vm
among
differenti
express
protein
protein
precursor
serum
amyloid
ficolin
precursor
ig
kappa
chain
c
region
upregul
remain
protein
apolipoprotein
e
serotransferrin
precursor
leucinerich
ambp
protein
vitamin
dbind
protein
haptoglobin
exhibit
reduc
express
level
pf
infect
patient
tabl
princip
compon
analysi
pca
use
extend
data
analysi
eda
modul
decyd
softwar
reveal
distinct
cluster
three
experiment
group
fm
vm
hc
figur
protein
present
least
spot
map
pass
filter
oneway
anova
test
includ
multivari
analysi
addit
hierarch
cluster
analysi
perform
use
protein
select
figur
protein
spot
found
significantli
differenti
express
malaria
subject
compar
healthi
individu
compar
analysi
perform
keep
leptospir
infect
febril
control
apprais
specif
identifi
malaria
relat
serum
marker
although
identifi
protein
exhibit
similar
trend
differenti
express
malaria
febril
control
interestingli
express
level
quit
candid
includ
serum
amyloid
haptoglobin
precursor
ficolin
precursor
hemopexin
precursor
precursor
retinolbind
protein
serotransferrin
precursor
vitronectin
precursor
found
alter
malaria
patient
fm
vm
leptospir
infect
tabl
alter
express
level
identifi
serum
protein
falciparum
vivax
malaria
leptospirosi
fc
illustr
bardiagrammat
figur
valid
differenti
express
protein
perform
use
differ
immunoassaybas
method
includ
immunoturbidimetr
assay
elisa
western
blot
confirm
result
proteom
analysi
haptoglobin
apolipoprotein
ai
apo
ai
concentr
directli
quantifi
turbidimetr
serum
sampl
malaria
patient
n
healthi
subject
n
febril
control
n
compar
healthi
control
fm
vm
patient
found
lower
serum
level
haptoglobin
apo
ai
mannwhitney
test
figur
b
mean
haptoglobin
concentr
found
gl
fm
vm
patient
respect
healthi
leptospirosi
fc
popul
exhibit
mean
valu
gl
gl
mean
se
likewis
apo
ai
exhibit
three
time
lower
mean
valu
malaria
patient
compar
healthi
subject
mgdl
fm
vm
hc
respect
febril
control
shown
mean
valu
mgdl
around
higher
malaria
patient
serum
retinolbind
protein
rbp
concentr
measur
sandwich
elisa
serum
level
rbp
found
significantli
lower
malaria
patient
figur
western
blot
analys
four
differenti
express
target
protein
haptoglobin
serum
amyloid
clusterin
retinolbind
protein
perform
subset
control
hc
n
fc
n
diseas
sampl
fm
vm
n
figur
cbb
stain
sdspage
gel
ponceau
stain
transfer
blot
contain
resolv
protein
indic
equal
load
sampl
lane
figur
western
blot
analysi
show
upregul
serum
amyloid
downregul
haptoglobin
clusterin
retinolbind
protein
fm
vm
patient
compar
healthi
febril
control
result
confirm
find
proteom
analysi
illustr
graphic
figur
thirti
differenti
express
serum
protein
identifi
fm
patient
compar
hc
subject
function
pathway
analysi
use
ingenu
pathway
analysi
ipa
candid
elig
network
analysi
focu
molecul
base
ipa
knowledg
base
criteria
two
overlap
interact
network
identifi
highest
score
network
includ
focu
molecul
second
network
includ
focu
molecul
figur
tabl
signific
relat
function
deriv
overlap
network
includ
lipid
metabol
protein
p
inflammatori
respons
protein
p
molecular
transport
protein
p
immun
cell
traffick
protein
p
humor
immun
respons
protein
p
accord
function
pathway
analysi
pf
infect
lead
alter
multipl
serum
protein
involv
divers
essenti
physiolog
pathway
includ
acut
phase
respons
ratio
p
primari
immunodefici
signal
ratio
p
tabl
function
analysi
differenti
express
protein
also
perform
use
protein
analysi
evolutionari
relationship
panther
databas
annot
visual
integr
discoveri
david
databas
panther
analysi
blood
coagul
system
p
identifi
moreov
heterotrimer
gprotein
signal
interleukin
signal
pathway
inflamm
mediat
chemokin
cytokin
signal
pathway
identifi
relat
physiolog
pathway
statist
signific
tabl
david
analysi
also
confirm
modul
complement
coagul
cascad
p
fm
tabl
accord
molecular
function
analysi
genespr
differenti
express
protein
identifi
fm
relat
bind
enzym
regul
activ
small
fraction
involv
transport
antioxid
activ
figur
tabl
major
protein
resid
extracellular
region
locat
cell
organel
macromolecular
complex
lumen
depict
figur
cellular
compon
analysi
tabl
biolog
process
analysi
genespr
indic
identifi
protein
involv
follow
biolog
process
respons
stimulu
biolog
regul
local
cellular
process
metabol
process
immun
system
multicellular
organism
process
biogenesi
signal
develop
process
figur
tabl
compar
analysi
vm
indic
pf
pv
infect
lead
alter
multipl
serum
protein
involv
divers
essenti
physiolog
pathway
includ
acut
phase
respons
signal
chemokin
cytokin
signal
complement
cascad
lipid
transport
metabol
blood
coagul
figur
tabl
figur
summar
differ
biolog
pathway
physiolog
function
associ
differenti
express
serum
protein
identifi
fm
vm
use
multipl
analyt
tool
serum
proteom
hc
fm
patient
fm
hc
sampl
label
respect
protein
refer
pool
intern
standard
label
graphic
fluoresc
intens
represent
select
statist
signific
differenti
express
protein
fm
patient
identifi
biolog
variat
analysi
bva
use
decyd
softwar
graph
show
decreaseincreas
standard
log
abund
spot
intens
fm
compar
hc
cohort
studi
n
initi
fidel
potenti
biomark
subset
contain
protein
identifi
tabl
evalu
discrimin
fm
hc
shown
figur
two
group
fm
hc
could
clearli
classifi
phenotyp
therebi
provid
addit
unbias
estim
class
predict
secondli
appli
class
predict
model
base
initi
cohort
n
independ
predict
assign
phenotyp
class
either
fm
hc
group
independ
blind
group
subject
newli
recruit
fm
patient
hc
model
provid
accur
phenotyp
classif
fm
n
hc
n
subject
accur
classifi
correct
phenotyp
tabl
achiev
overal
predict
accuraci
independ
predict
hc
n
fm
n
use
partial
least
squar
discrimin
analysi
plsda
final
valid
phase
compar
perform
biomark
subset
use
three
wellknown
machinelearn
method
decis
tree
bay
support
vector
machin
svm
tabl
summar
percentag
sampl
classifi
model
train
crossvalid
independ
predict
respect
use
three
differ
classifi
achiev
overal
predict
accuraci
svm
decis
tree
bay
well
blind
predict
use
biomark
dataset
fm
hc
n
differenti
express
protein
tabl
identifi
implic
potenti
classifi
discrimin
fm
vm
patient
healthi
subject
employ
similar
type
analysi
figur
achiev
overal
predict
accuraci
blind
predict
n
use
plsda
tabl
summar
percentag
sampl
classifi
model
train
crossvalid
independ
predict
respect
final
valid
phase
achiev
overal
predict
accuraci
decis
tree
svm
respect
follow
bay
blind
predict
use
biomark
dataset
fm
n
vm
n
hc
n
next
round
multivari
statist
analysi
perform
evalu
effici
identifi
serum
protein
discrimin
fm
vm
fc
patient
suffer
leptospir
infect
figur
differenti
express
protein
tabl
identifi
implic
potenti
classifi
tabl
summar
percentag
sampl
correctli
classifi
model
train
crossvalid
independ
predict
respect
use
differ
classifi
achiev
overal
predict
accuraci
decis
tree
svm
bay
plsda
independ
predict
fm
n
vm
n
lep
n
tabl
provid
addit
detail
confid
measur
obtain
blind
predict
subject
use
given
statist
method
confid
measur
defin
strength
predict
belong
particular
class
receiv
oper
characterist
roc
curv
analysi
carri
evalu
individu
perform
classifi
protein
apolipoprotein
ai
haptoglobin
retinolbind
protein
malaria
predict
serum
protein
use
potenti
classifi
along
candid
build
statist
sampl
class
predict
model
employ
plsda
protein
multipl
spot
gel
repres
spot
detail
provid
exact
valu
spot
provid
tabl
classif
method
fm
vm
fc
hc
discrimin
area
roc
curv
auc
indic
accuraci
differ
classifi
protein
distinguish
fm
vm
leptospirosi
hc
figur
roc
curv
demonstr
apolipoprotein
ai
auc
haptoglobin
auc
effici
predictor
protein
falciparum
malaria
detect
cut
valu
mgdl
apo
ai
reveal
specif
sensit
respect
haptoglobin
cut
valu
gl
provid
specif
sensit
predict
pf
infect
retinolbind
protein
auc
exhibit
moder
sensit
specif
fm
cut
valu
mgml
figur
tabl
precondit
effici
classifi
protein
vivax
malaria
also
evalu
found
highli
appreci
apo
ai
auc
sensit
specif
threshold
valu
mg
dl
haptoglobin
auc
sensit
specif
threshold
valu
gl
retinolbind
protein
auc
sensit
specif
threshold
valu
mgml
well
figur
tabl
accuraci
classifi
serum
protein
predict
leptospirosi
fc
also
test
figur
although
apo
ai
auc
sensit
specif
threshold
valu
mgdl
exhibit
fine
profici
detect
leptospir
infect
perform
haptoglobin
auc
sensit
specif
threshold
valu
gl
retinolbind
protein
auc
sensit
specif
threshold
valu
mg
ml
poor
tabl
roc
analysi
reveal
serum
level
classifi
protein
particularli
apo
ai
haptoglobin
exhibit
good
correl
plasmodi
infect
could
investig
potenti
surrog
protein
marker
malaria
among
four
differ
speci
plasmodia
caus
malaria
human
pf
pv
account
total
malaria
case
worldwid
studi
use
proteom
deciph
alter
human
serum
proteom
due
pf
infect
gain
insight
diseas
pathogenesi
host
immun
respons
also
perform
compar
analysi
host
respons
pf
pv
infect
compar
proteom
analysi
plasmodi
leptospir
infect
febril
control
perform
apprais
gener
febril
respons
specifi
malaria
relat
serum
marker
ultim
aspir
studi
identifi
potenti
marker
protein
distinguish
malaria
patient
healthi
febril
control
well
discrimin
pf
pv
infect
high
accuraci
although
number
earlier
proteom
immunoassaybas
studi
demonstr
alter
limit
set
serum
protein
malaria
hitherto
attempt
comprehens
analysi
establish
panel
classifi
protein
readili
discrimin
fm
vm
group
control
result
indic
variou
vital
physiolog
pathway
includ
acut
phase
respons
signal
cytokin
chemokin
signal
complement
cascad
lipid
transport
metabol
blood
coagul
modul
pf
pv
infect
figur
alter
level
sever
acut
phase
protein
app
multipl
member
serum
complement
cascad
well
complement
regulatori
protein
tabl
due
plasmodi
infect
consist
earlier
find
increas
express
level
circul
acutephas
amyloid
protein
like
serum
amyloid
p
provid
nonspecif
resist
preerythrocyt
stage
plasmodium
limit
tissu
damag
promot
rapid
return
homeostasi
interestingli
human
serum
paraoxonas
hdlassoci
esteras
protect
lipoprotein
oxid
found
downregul
falciparum
malaria
patient
acut
inflammatori
stimuli
lead
reciproc
regul
saa
decreas
serum
activ
context
falciparum
malaria
may
part
attribut
higher
saa
level
cours
diseas
progress
malari
parasit
grow
erythrocyt
degrad
hemoglobin
gener
reactiv
oxygen
speci
ro
lead
increas
oxid
stress
within
erythrocyt
outsid
parasit
cell
result
circumv
situat
enhanc
plasma
level
antioxid
defens
associ
enzymesprotein
superoxid
observ
acut
malaria
patient
fm
vm
patient
identifi
elev
serum
level
hemopexin
hemebind
protein
provid
second
line
defens
hemoglobinmedi
oxid
damag
intravascular
hemolysi
increas
product
acut
phase
protein
host
defens
system
could
help
circumv
proinflammatori
respons
oxid
stress
gener
patient
pf
pv
infect
contrast
haptoglobin
hp
found
significantli
downregul
fm
vm
patient
hp
remov
free
hemoglobin
hb
releas
parasit
induc
hemolysi
disappear
hphb
complex
lead
malaria
associ
hypoor
ahaptoglobinemia
promis
inflammatori
marker
evalu
sever
plasmodium
infect
earlier
report
demonstr
possibl
role
app
epidemiolog
marker
malaria
erythrocyt
invas
essenti
gateway
malaria
diseas
key
target
diseas
intervent
signal
via
erythrocyt
beta
receptor
heterotrimer
guanin
nucleotidebind
protein
ga
regul
entri
human
malaria
parasit
p
falciparum
disrupt
interact
galpha
subunit
gs
protein
receptor
result
reduc
erythrocyt
invas
parasit
subsequ
low
level
parasitemia
downregul
regul
gprotein
signal
fm
patient
might
due
host
respons
combat
parasit
infect
convers
upregul
apolipoprotein
e
observ
malaria
patient
apolipoprotein
also
inhibit
plasmodium
invas
sinc
share
cell
entri
mediat
heparan
sulphat
proteoglycan
andor
low
densiti
lipoprotein
receptor
parasit
pathway
analys
dens
connect
network
base
result
provid
insight
underli
molecular
mechan
malaria
earli
accur
diagnosi
critic
effect
treatment
manag
malaria
recent
year
multivari
project
method
success
appli
analyz
biolog
data
obtain
genom
transcriptom
proteom
approach
studi
variou
human
diseas
implic
diagnost
clinic
manag
subset
protein
identifi
proteom
analysi
use
build
statist
sampl
class
predict
model
identifi
classifi
marker
protein
fm
vm
hc
discrimin
interestingli
two
key
classifi
protein
serum
amyloid
haptoglobin
differenti
express
consist
malaria
patient
fm
vm
compar
control
subject
hc
fc
remain
statist
signific
fdr
benjaminihochberg
bonferroni
correct
pvalu
obtain
ttest
indic
strong
correl
express
level
two
serum
protein
plasmodi
infect
recognit
abil
predict
model
fm
vm
hc
discrimin
crossvalid
almost
tabl
control
statist
fals
discoveri
rate
use
three
distinct
iter
valid
step
kfold
crossvalid
algorithm
origin
cohort
ii
applic
marker
subset
identifi
origin
cohort
classifi
newli
recruit
patient
iii
perform
marker
subset
valid
use
three
wellknown
machin
learn
method
studi
biolog
replic
investig
ie
proteom
profil
repres
differ
human
subject
henc
dataset
character
low
homogen
confer
protocol
high
level
variabl
complex
inde
extrem
heterogen
larg
biolog
variat
includ
gender
age
genet
factor
dietari
consider
environment
factor
drug
treatment
affect
detect
valid
establish
gold
standard
serolog
biomark
nonetheless
accur
discrimin
among
fm
vm
control
group
obtain
variou
predict
model
basi
differenti
express
candid
protein
testifi
excel
potenti
analyt
approach
detect
discrimin
vm
fm
figur
figur
also
note
uncompl
fm
vm
patient
divers
rang
parasitemia
mainli
low
moder
parasitem
parasitesml
blood
use
valid
predict
model
tabl
even
discrimin
accuraci
studi
appreci
indic
capabl
analyt
approach
detect
lowlevel
parasitemia
highli
promis
diagnost
point
view
although
diagnosi
malaria
basi
microscop
examin
thin
thick
smear
peripher
blood
commonli
use
wellaccept
method
requir
highli
train
personnel
smear
interpret
frequent
fail
distinguish
mixedspeci
infect
diagnos
patient
submicroscop
parasitemia
detect
limit
blood
smear
mani
area
endem
oper
characterist
microscopi
poor
quest
earli
accur
diagnosi
malaria
discrimin
pf
pv
mix
infect
establish
serum
protein
marker
attract
approach
apart
clinic
symptom
convent
microscop
examin
blood
smear
end
classifi
candid
protein
identifi
studi
serum
amyloid
paraoxonas
apolipoprotein
ai
e
haptoglobin
hemopexin
complement
import
due
function
relev
malaria
pathogenesi
could
investig
potenti
surrog
protein
marker
clinic
implic
variou
rapid
diagnost
test
rdt
practic
malaria
diagnosi
diagnos
infect
basi
detect
parasit
proteinsantigen
eg
histidinerich
protein
ii
hrpii
lactat
dehydrogenas
ldh
wherea
first
time
demonstr
discrimin
fm
vm
patient
base
protein
express
human
host
malaria
rdt
use
regularli
clinic
due
low
cost
sensit
less
detect
time
howev
analysi
frozen
specimen
blood
parasitaem
patient
use
exist
rdt
bit
challeng
anoth
limit
factor
shelflif
rdt
sinc
exist
rdt
deterior
rapidli
exposur
moistur
humid
high
temperatur
moreov
signific
variat
may
appear
technician
rdt
prepar
result
interpret
process
depend
experi
perform
manual
profici
visual
percept
end
serum
protein
marker
potenti
candid
develop
altern
sensit
diagnost
approach
malaria
develop
highli
sensit
biosensor
identifi
surrog
protein
might
attract
diagnost
point
view
summari
present
studi
demonstr
applic
diagnost
proteom
deciph
host
respons
human
malaria
parasit
pf
pv
identifi
potenti
candid
biomark
two
plasmodi
infect
comprehens
proteom
analysi
identifi
multipl
differenti
express
serum
protein
versatil
biolog
function
indic
modul
multipl
vital
physiolog
pathway
fm
vm
patient
anticip
inform
obtain
studi
provid
valuabl
insight
underli
molecular
mechan
malaria
may
help
establish
earli
detect
surrog
infecti
parasit
diseas
meet
need
better
diagnost
effect
therapi
identifi
classifi
protein
serum
amyloid
apolipoprotein
ai
e
haptoglobin
success
discrimin
fm
vm
might
prognost
host
marker
diseas
sever
end
would
interest
elucid
fate
identifi
serum
protein
sever
malaria
patient
could
futur
continu
studi
diagnost
impact
identifi
serum
biomark
clinic
specif
malaria
predict
establish
investig
diseas
pattern
larg
clinic
cohort
proteom
analysi
perform
approv
institut
ethic
committe
seth
gs
medic
colleg
king
edward
memori
hospit
parel
mumbai
india
patient
suffer
uncompl
pf
pv
infect
asexu
parasit
count
per
ml
blood
select
studi
total
patient
uncompl
fm
n
vm
n
confirm
microscop
examin
thin
peripher
blood
smear
follow
rdt
enrol
proteom
studi
addit
blood
specimen
collect
age
sex
match
leptospirosi
patient
n
febril
control
healthi
subject
n
perform
compar
proteom
analysi
written
inform
consent
taken
particip
malaria
patient
control
prior
sampl
collect
process
demograph
epidemiolog
clinic
detail
malaria
patient
febril
control
fc
select
proteom
studi
provid
tabl
blood
sampl
ml
collect
antecubit
vein
subject
use
serum
separ
tube
bd
vacutainerh
bd
bioscienc
immedi
blood
collect
tube
kept
ice
min
clot
serum
separ
perform
describ
previous
brief
clot
sampl
centrifug
rpm
min
serum
collect
care
upper
surfac
collect
serum
divid
multipl
aliquot
store
time
analysi
prevent
protein
degrad
prior
proteom
analysi
maximum
freezethaw
cycl
allow
serum
sampl
reduc
preanalyt
variat
crude
serum
dilut
five
time
phosphat
buffer
ph
subject
mild
sonic
vibra
cell
sonic
use
follow
set
cycl
sec
puls
sec
gap
amplitud
sonic
top
two
highabund
serum
protein
albumin
igg
remov
use
albumin
igg
deplet
spintrap
ge
healthcar
follow
manufactur
instruct
extract
protein
deplet
serum
sampl
perform
employ
tcaaceton
precipit
method
describ
chen
et
al
slight
modif
brief
deplet
serum
sampl
dilut
ratio
icecold
aceton
contain
wv
tca
uniform
mix
perform
use
mild
vortex
sec
mixtur
allow
incub
hr
protein
precipit
complet
incub
period
tube
centrifug
g
min
supernat
separ
kept
fresh
microcentrifug
tube
pellet
dissolv
rehydr
buffer
urea
thiourea
wv
chap
vv
ipg
buffer
ph
linear
mm
dtt
trace
bromophenol
blue
order
precipit
remain
amount
protein
present
collect
tcaacetonecontain
supernat
ml
icecold
aceton
ad
tube
sampl
subject
one
addit
round
precipit
extract
process
case
prior
resuspens
rehydr
buffer
pellet
briefli
airdri
prior
proteom
analys
protein
concentr
sampl
quantifi
use
kit
ge
healthcar
follow
manufactur
instruct
total
mg
deplet
serum
protein
extract
dissolv
ml
rehydr
buffer
load
ph
rang
ipg
strip
cm
underw
passiv
rehydr
hr
isoelectr
focus
ief
perform
ettan
ipgphor
isoelectr
focus
unit
ge
healthcar
overal
approxim
kvh
use
follow
voltag
set
v
h
step
hold
v
h
step
hold
v
h
step
hold
v
h
gradient
v
h
step
hold
complet
ief
focus
ipg
strip
store
second
dimension
analysi
perform
preced
second
dimension
separ
strip
equilibr
reduc
alkyl
protein
min
use
equilibr
buffer
contain
urea
mm
trishcl
ph
vv
glycerol
wv
sd
wv
bromophenol
blue
prior
use
wv
dtt
wv
iaa
ad
first
reduc
second
alkyl
equilibr
buffer
respect
second
dimens
perform
sd
polyacrylamid
gel
use
ettan
daltsix
electrophoresi
unit
ge
healthcar
electrophoresi
gelcod
blue
safe
protein
stain
thermo
scientif
usa
util
visual
protein
spot
protein
extract
subject
run
duplic
verifi
reproduc
curtail
technic
artifact
cydy
resuspend
anhydr
n
ndimethylformamid
dmf
prepar
stock
dye
concentr
mm
work
solut
pmol
cydy
made
dilut
stock
dmf
sampl
test
control
label
mixtur
equal
amount
sampl
analyz
experi
regard
intern
standard
label
third
fluoresc
dye
accord
manufactur
instruct
ge
healthcar
brief
ph
sampl
adjust
use
mm
naoh
mg
protein
sampl
malaria
control
hcfc
intern
standard
separ
label
pmol
cydy
addit
cydy
sampl
incub
ice
dark
label
reaction
stop
addit
mm
lysin
follow
incub
ice
addit
min
dyeswap
perform
label
test
control
sampl
elimin
type
dye
effect
label
sampl
label
mix
dilut
rehydr
buffer
load
cm
ph
ipg
strip
subsequ
ief
sdspage
separ
perform
follow
protocol
previous
describ
section
imag
acquisit
data
analysi
perform
describ
previous
brief
stain
gel
scan
use
labscan
softwar
version
ge
healthcar
analyz
use
imagemast
platinum
softwar
ge
healthcar
compar
analysi
fm
sampl
perform
creat
differ
match
set
use
hc
sampl
refer
spot
detect
paramet
specifi
smooth
salienc
min
area
automat
detect
spot
manual
refin
perform
elimin
contamin
artifact
streak
dust
particl
spot
quantif
perform
vol
valu
use
imagemast
algorithm
provid
normal
valu
remain
rel
independ
variat
due
stain
protein
load
gel
analysi
tabl
histogram
imag
gener
softwar
use
analysi
gel
scan
use
typhoon
variabl
mode
imag
ge
healthcar
mm
resolut
employ
suitabl
excitationemiss
wavelength
cydy
nm
nm
nm
scan
gel
imag
crop
properli
use
imagequ
softwar
version
ge
healthcar
prior
import
decyd
softwar
version
ge
healthcar
compar
analysi
rel
protein
quantif
across
fm
control
sampl
compar
analysi
perform
use
two
differ
modul
differenti
ingel
analysi
dia
biolog
variat
analysi
bva
decyd
softwar
preliminari
analysi
perform
use
dia
modul
detect
spot
cumul
imag
deriv
merg
three
individu
imag
ingel
link
imag
set
malaria
control
intern
standard
permit
pairwis
comparison
normal
malaria
sampl
mix
standard
present
gel
offer
spotwis
protein
abund
ratio
analysi
perform
use
bva
modul
get
variat
protein
express
level
two
experiment
group
fm
vs
vm
fm
vs
hc
vm
vs
hc
across
set
statist
signific
averag
ratio
express
analyz
student
ttest
protein
spot
exhibit
differenti
express
reproduc
statist
signific
consid
analysi
bonferroni
correct
reduc
type
error
pvalu
obtain
student
ttest
perform
use
standard
bonferroni
procedur
recogn
marker
protein
strong
connect
diseas
state
remain
signific
bonferroni
correct
sinc
bonferroni
correct
extrem
conserv
compar
less
stringent
fals
discoveri
rate
fdr
correct
also
perform
detail
benjamini
hochberg
also
perform
compar
analysi
fm
dataset
obtain
studi
previous
publish
vm
data
cluster
three
experiment
group
fm
vm
hc
perform
princip
compon
analysi
pca
use
algorithm
includ
extend
data
analysi
eda
modul
decyd
softwar
protein
present
least
spot
map
pass
filter
oneway
anova
test
includ
multivari
analysi
addit
hierarch
cluster
analysi
perform
use
protein
select
criteria
statist
signific
ttest
differenti
express
protein
spot
identifi
regular
experi
select
ms
analysi
establish
protein
ident
gelcod
blue
stain
prepar
gel
contain
much
higher
amount
protein
mg
use
excis
spot
interest
specifi
experi
spot
excis
perform
manual
ingel
digest
protein
separ
gel
electrophoresi
perform
describ
shevchenko
et
al
slight
modif
short
gel
slice
cut
small
cube
mm
wash
ml
stain
remov
solut
mm
ammonium
bicarbon
buffer
remov
cbb
stain
wash
ml
mm
ammonium
bicarbonateacetonitril
vv
ad
follow
min
incub
occasion
vortex
room
temperatur
incub
solut
remov
two
step
repeat
three
time
ml
reduct
solut
mm
dtt
mm
ammonium
bicarbon
ad
gel
piec
incub
min
air
thermostat
tube
allow
cool
room
temperatur
incub
ml
mm
ammonium
bicarbon
buffer
ad
wash
gel
piec
follow
dehydr
mm
ammonium
bicarbonateacetonitril
vv
step
alkyl
solut
mm
iaa
mm
ammonium
bicarbon
ad
tube
contain
gel
piec
incub
min
room
temperatur
dark
rehydr
dehydr
step
perform
twice
gel
piec
allow
dri
gel
slice
properli
dri
trypsin
solut
trypsin
gold
promega
madison
wisconsin
unit
state
ad
gel
piec
keep
ratio
trypsin
protein
around
ww
incub
ice
min
absorpt
solut
step
tube
incub
overnight
adequ
amount
ammonium
bicarbon
buffer
ad
cover
gel
piec
extract
digest
peptid
gel
matrix
perform
use
ml
extract
buffer
formic
acid
acetonitril
complet
enzymat
reaction
extract
step
repeat
thrice
ensur
maximum
recoveri
digest
peptid
collect
supernat
pool
singl
tube
concentr
use
speed
vac
extract
trypsin
digest
sampl
process
use
ziptip
pipett
tip
millipor
usa
accord
manufactur
protocol
remov
salt
enrich
peptid
subsequ
enrich
purif
ziptip
pipett
tip
peptid
mixtur
dissolv
ml
chca
matrix
solut
mgml
chca
tfa
spot
onto
freshli
clean
maldi
target
plate
spot
allow
dri
min
room
temperatur
air
dri
crystal
spot
analys
use
malditof
tof
mass
spectromet
ab
sciex
framingham
link
seri
explor
softwar
version
mass
spectra
record
reflector
mode
within
mass
rang
da
use
nd
yag
nm
laser
acceler
voltag
extract
voltag
kept
kv
kv
respect
six
point
calibr
instrument
automat
perform
peptid
standard
kit
ab
sciex
includ
mz
angiotensin
mz
b
mz
acth
mz
acth
mz
acth
mz
ms
spectra
obtain
accumul
shot
msm
spectra
acquir
abund
precursor
ion
total
accumul
laser
shot
collis
energi
kv
ms
survey
scan
complet
data
process
gener
list
precursor
ion
interrog
msm
combin
ms
ms
ms
peak
list
search
use
gp
tm
explor
softwar
version
ab
sciex
protein
identif
perform
msm
ion
search
use
mascot
version
http
www
martixsciencecom
search
engin
swissprot
databas
search
carri
follow
paramet
entri
taxonomi
trypsin
digest
one
miss
cleavag
fix
modif
carbamidomethyl
cystein
residu
variabl
modif
oxid
methionin
residu
mass
toler
ppm
ms
da
msm
identifi
protein
least
two
uniqu
match
peptid
select
analysi
report
protein
protein
identif
confid
interv
quantit
immunolog
measur
two
differenti
express
protein
identifi
studi
haptoglobin
apolipoprotein
ai
serum
sampl
healthi
control
n
falciparum
malaria
n
leptospirosi
patient
n
perform
use
coba
integra
plu
system
roch
serum
concentr
two
target
protein
vivax
malaria
taken
account
compar
analysi
previou
report
crude
individu
serum
sampl
subject
directli
immunoturbidimetr
quantif
use
tinaqu
kit
roch
diagnost
accord
manufactur
instruct
sampl
control
automat
predilut
nacl
solut
instrument
immunolog
assay
target
protein
form
precipit
specif
antiserum
determin
turbidimetr
nm
antihuman
haptoglobin
rabbit
apo
ai
sheep
antibodi
appli
immunoturbidimetr
quantif
haptoglobin
apo
ai
respect
instrument
monitor
absorb
measur
mode
absorb
increas
directli
proport
concentr
target
protein
quantif
anoth
interest
target
retinolbind
protein
rbp
perform
use
elisa
concentr
serum
sampl
hc
n
fc
n
fm
n
vm
n
patient
measur
use
assaymax
human
retinolbind
elisa
kit
cat
assaypro
usa
follow
manufactur
instruct
briefli
quantit
sandwich
enzym
assay
employ
standard
serum
sampl
hc
fc
fm
vm
dilut
subject
micropl
precoat
polyclon
antibodi
specif
sampl
sandwich
immobil
antibodi
biotinyl
polyclon
antibodi
specif
recogn
streptavidinperoxidas
complex
color
develop
perform
addit
peroxidas
enzym
substrat
optic
densiti
measur
nm
nm
use
spectramax
e
molecular
devic
usa
prior
western
blot
experi
protein
concentr
sampl
malaria
patient
n
fc
n
hc
n
accur
estim
use
kit
ge
healthcar
bca
protein
assay
thermo
fisher
scientif
western
blot
analysi
perform
describ
previous
briefli
serum
protein
separ
sdspage
mg
per
track
transfer
onto
pvdf
membran
semidri
condit
use
ecl
semidri
transfer
unit
ge
healthcar
western
blot
perform
use
monoclon
polyclon
antibodi
serum
amyloid
santacruz
biotechnolog
haptoglobin
santacruz
biotechnolog
clusterin
santacruz
biotechnolog
retinolbind
protein
rbp
santacruz
biotechnolog
appropri
secondari
antibodi
conjug
hrp
genei
merck
candid
protein
valid
select
basi
fold
chang
possibl
associ
protein
malaria
pathobiolog
access
requir
antibodi
imagequ
softwar
version
ge
healthcar
appli
quantit
signal
intens
band
western
blot
differenti
express
serum
protein
fm
subject
function
pathway
analysi
use
ipavers
ingenuityh
system
wwwingenuitycom
determin
associ
identifi
protein
variou
physiolog
pathway
signific
associ
dataset
identifi
networkspathway
consid
basi
two
paramet
ratio
pvalu
differenti
express
protein
fm
patient
also
analyz
use
panther
system
version
http
www
pantherdborg
david
databas
version
http
davidabccncifcrfgovhomejsp
list
uniprot
access
dataset
upload
tab
delimit
text
format
map
refer
homo
sapien
dataset
extract
summar
function
annot
associ
individu
group
gene
protein
gene
ontolog
go
categori
protein
assign
use
genespr
softwar
packag
version
agil
technolog
santa
clara
usa
sinc
go
vocabulari
organ
hierarch
fashion
second
level
go
term
present
balanc
go
term
specif
maxim
coverag
go
term
enrich
two
protein
consid
addit
signific
pvalu
enrich
comput
use
hypergeometr
probabl
distribut
identifi
go
categori
repres
protein
rel
represent
biolog
genom
human
creat
use
inform
avail
ncbi
ftp
ftp
ncbinlmnihgovgenedata
determin
biolog
pathway
signific
enrich
input
protein
algorithm
genespr
softwar
packag
perform
standard
hypergeometr
calcul
obtain
pvalu
signifi
enrich
prior
analysi
manual
curat
biolog
pathway
reactom
biocarta
nci
pathwaycommon
biopax
level
format
popul
genespr
databas
pathway
signific
pvalu
chosen
subsequ
analysi
interpret
use
genespr
pathway
databas
creat
shortest
connect
network
select
pathway
expand
select
algorithm
perform
network
includ
first
second
degre
neighbor
expand
select
use
genespr
pathway
databas
find
expans
entiti
take
seri
expans
connect
process
functionsoth
biomolecul
given
entiti
protein
algorithm
allow
list
process
function
given
entiti
particip
appli
proteom
data
obtain
analys
discrimin
among
fm
vm
fc
hc
group
use
multivari
statist
analysi
protein
haptoglobin
apolipoprotein
ai
hemopexin
apolipoprotein
e
serum
amyloid
identifi
tabl
protein
haptoglobin
apolipoprotein
ai
hemopexin
apolipoprotein
e
serum
amyloid
serum
amyloid
p
serum
paraoxonas
arylesteras
identifi
tabl
use
develop
statist
classifi
design
categor
predict
clinic
phenotyp
ie
fm
vm
hc
discrimin
malaria
fm
vm
fc
leptospirosi
statist
sampl
class
predict
perform
basi
differenti
express
level
candid
protein
serum
amyloid
hemopexin
apolipoprotein
e
haptoglobin
retinolbind
protein
apolipoprotein
ai
tabl
select
candid
protein
execut
basi
level
differenti
express
abil
discrimin
clinic
phenotyp
multivari
statist
analysi
machin
learn
data
mean
center
scale
logarithm
transform
perform
order
lower
rel
larg
differ
among
respect
spot
abund
data
addit
normal
use
quantil
method
correct
batch
differ
level
valid
use
establish
reliabl
identifi
differenti
express
protein
detect
correct
phenotyp
class
use
mass
profil
profession
mpp
use
plsda
svm
decis
tree
bay
implement
mpp
softwar
packag
version
agil
technolog
santa
clara
usa
multivari
machin
learn
analysi
studi
partial
least
squar
regress
method
use
inform
contain
x
data
matrix
predictor
variabl
predict
behavior
data
matrix
respons
variabl
pl
method
model
x
variabl
simultan
find
latent
variabl
x
predict
latent
variabl
applic
pl
classif
method
indic
plsda
svm
separ
two
class
gener
hyperplan
highdimension
featur
space
maxim
distanc
hyperplan
closest
train
exampl
decis
tree
sampl
get
classifi
follow
appropri
path
decis
tree
naiv
bayesian
model
built
base
probabl
distribut
function
train
data
along
featur
sinc
decis
tree
bay
directli
handl
multiclass
problem
use
default
paramet
techniqu
svm
train
use
sequenti
minim
optim
linear
kernel
valid
obtain
predict
model
perform
use
standard
kfold
crossvalid
procedur
observ
input
data
randomli
divid
three
equal
part
two
part
use
model
train
remain
sampl
classifi
use
construct
model
whole
process
repeat
time
effici
classifi
protein
haptoglobin
apolipoprotein
ai
retinolbind
protein
predict
malaria
fm
vm
leptospirosi
febril
control
analyz
use
receiv
oper
characterist
roc
curv
plot
true
posit
sensit
vs
fals
posit
possibl
cutoff
use
graphpad
prism
softwar
packag
version
roc
curv
analysi
perform
classifi
protein
absolut
serum
concentr
valu
immunoturbidimetr
assayelisa
measur
sensit
specif
valu
marker
protein
calcul
differ
threshold
point
twosid
pvalu
less
consid
statist
signific
figur
evalu
deplet
effici
albumin
igg
human
serum
two
major
highabund
serum
protein
albumin
igg
remov
use
albumin
igg
deplet
spintrap
ge
healthcar
reduc
dynam
rang
serum
protein
concentr
level
albumin
igg
cbb
stain
gel
deplet
mg
total
serum
protein
focus
linear
ph
ipg
strip
cm
separ
polyacrylamid
gel
deplet
top
two
highabund
protein
albumin
igg
introduc
nearli
twofold
increas
overal
spot
number
gel
b
level
albumin
igg
cbb
stain
gel
deplet
show
effici
deplet
process
mg
total
crude
c
deplet
serum
protein
load
onto
lane
separ
polyacrylamid
gel
c
densitometr
analysi
gel
reveal
around
deplet
albumin
igg
respect
pdf
figur
trend
differenti
express
protein
falciparum
malaria
patient
visual
gel
repres
gel
serum
healthi
control
fm
patient
mg
total
serum
protein
focus
linear
ph
ipg
strip
cm
separ
polyacrylamid
gel
stain
gel
code
blue
stain
protein
spot
exhibit
significantli
alter
express
level
mark
gel
b
c
regul
protein
express
level
fm
patient
imag
statist
signific
differenti
express
spot
analyz
use
softwar
data
repres
mean
sem
n
pdf
figur
ipa
defin
interact
network
associ
differenti
express
protein
falciparum
malaria
differenti
express
serum
protein
identifi
fm
patient
enter
focu
molecul
analyt
softwar
gener
biolog
process
pathway
molecular
network
associ
identifi
protein
topscor
network
score
cell
signal
molecular
transport
vitamin
miner
metabol
network
incorpor
differenti
express
protein
focu
molecul
b
second
network
lipid
metabol
molecular
transport
small
molecul
biochemistri
score
network
incorpor
focu
molecul
green
red
symbol
repres
protein
upregul
falciparum
malaria
respect
identifi
studi
white
symbol
repres
associ
protein
identifi
function
analysi
differ
express
level
achiev
statist
signific
studi
pdf
figur
gene
ontolog
go
term
molecular
function
cellular
compon
biolog
process
associ
differenti
express
serum
protein
identifi
falciparum
malaria
total
gene
ontolog
go
term
identifi
distribut
second
level
go
term
enrich
two
protein
shown
molecular
function
cellular
compon
b
biolog
process
c
pdf
figur
biolog
process
regul
differenti
express
serum
protein
identifi
falciparum
vivax
malaria
patient
regul
base
natur
languag
process
perform
medlin
abstract
avail
genespr
softwar
packag
version
agil
technolog
identifi
process
common
plasmodi
infect
b
specif
p
falciparum
c
specif
p
vivax
infect
red
triangl
blue
squar
repres
posit
neg
regul
respect
pdf
figur
discrimin
falciparum
vivax
malaria
healthi
control
basi
differenti
express
select
serum
protein
plsda
score
plot
fm
red
sphere
n
hc
green
sphere
n
sampl
base
differenti
express
protein
tabl
identifi
use
b
fm
red
sphere
n
vm
blue
sphere
n
hc
green
sphere
n
sampl
base
differenti
express
protein
tabl
